Biological Treatment for Psoriasis and the Risk of Herpes Zoster: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of Dermatological Treatment - United Kingdom
doi 10.1080/09546634.2018.1445193
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Informa UK Limited

Related search

Serious Infections in Patients With Self-Reported Psoriatic Arthritis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Treated With Biologics

BMC Rheumatology
Rheumatology
2019English

Inequalities in Access to Biological Treatments for Psoriasis: Results From the Italian Psocare Registry

British Journal of Dermatology
DermatologyMedicine
2017English

Risk of Serious Infection, Opportunistic Infection and Herpes Zoster Among Patients With Psoriasis in the United Kingdom

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Biological Therapy for Psoriasis and Risk of Cancer

British Journal of Dermatology
DermatologyMedicine
2018English

From the Medical Board of the National Psoriasis Foundation: Treatment Targets for Plaque Psoriasis

Journal of the American Academy of Dermatology
Dermatology
2017English

Immunosuppressants for the Treatment of Psoriasis

Journal of Nihon University Medical Association
2017English

Adalimumab for the Treatment of Psoriasis

Health Technology Assessment
MedicineHealth Policy
2009English

Old and New Biological Therapies for Psoriasis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Tofacitinib for the Treatment of Psoriasis and Psoriatic Arthritis

Expert Review of Clinical Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy